BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11805541)

  • 1. Cyclooxygenase-2 selective inhibitors and the kidney.
    Breyer MD; Hao C; Qi Z
    Curr Opin Crit Care; 2001 Dec; 7(6):393-400. PubMed ID: 11805541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
    Galli G; Panzetta G
    G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.
    Qi Z; Hao CM; Langenbach RI; Breyer RM; Redha R; Morrow JD; Breyer MD
    J Clin Invest; 2002 Jul; 110(1):61-9. PubMed ID: 12093889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selective inhibitors of type 2 cyclooxygenase: less renal effects than the classical non-steroidal anti-inflammatory agents].
    Chiolero A; Würzner G; Burnier M
    Nephrologie; 2000; 21(8):425-30. PubMed ID: 11213386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal effects of cyclooxygyenase-2-selective inhibitors.
    Brater DC
    J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S15-20; discussion S21-3. PubMed ID: 11992745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent development of selective cyclooxygenase-2 inhibitors].
    Kawai S
    Nihon Rinsho; 2002 Dec; 60(12):2370-7. PubMed ID: 12510364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSAIDs and the kidney revisited: are selective cyclooxygenase-2 inhibitors safe?
    Eras J; Perazella MA
    Am J Med Sci; 2001 Mar; 321(3):181-90. PubMed ID: 11269794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are cyclooxygenase-2-selective inhibitors safe for the kidneys?
    Phan O; Meier P; Burnier M
    Joint Bone Spine; 2003 Aug; 70(4):237-41. PubMed ID: 12951303
    [No Abstract]   [Full Text] [Related]  

  • 10. [Renal tolerance of selective inhibitors of cyclooxygenase type 2].
    Deray G
    Presse Med; 2001 Oct; 30(30):1507-12. PubMed ID: 11712212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution.
    Noroian G; Clive D
    Drug Saf; 2002; 25(3):165-72. PubMed ID: 11945113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase 2 and the kidney.
    Breyer MD; Harris RC
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):89-98. PubMed ID: 11195058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors.
    Gambaro G; Perazella MA
    J Intern Med; 2003 Jun; 253(6):643-52. PubMed ID: 12755960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 inhibitors and the kidney.
    Appel GB
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S37-40. PubMed ID: 11695250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Benefits and risks of cyclooxygenase-2-selective inhibitor nonsteroidal antiinflammatory drugs].
    Vallano A; Llop R; Bosch M
    Med Clin (Barc); 2002 Oct; 119(11):429-34. PubMed ID: 12381279
    [No Abstract]   [Full Text] [Related]  

  • 17. COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention.
    Ballinger A; Smith G
    Expert Opin Pharmacother; 2001 Jan; 2(1):31-40. PubMed ID: 11336566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors.
    Cheng HF; Harris RC
    Curr Pharm Des; 2005; 11(14):1795-804. PubMed ID: 15892676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors.
    Komers R; Anderson S; Epstein M
    Am J Kidney Dis; 2001 Dec; 38(6):1145-57. PubMed ID: 11728945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 inhibition and renal physiology.
    Harris RC
    Am J Cardiol; 2002 Mar; 89(6A):10D-17D. PubMed ID: 11909556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.